Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) closed at $14.14 down -1.26% from its previous closing price of $14.32. In other words, the price has decreased by -$1.26 from its previous closing price. On the day, 2.31 million shares were traded. RDY stock price reached its highest trading level at $14.35 during the session, while it also had its lowest trading level at $14.06.
Ratios:
For a deeper understanding of Dr. Reddy’s Laboratories Ltd. ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 86.06. For the most recent quarter (mrq), Quick Ratio is recorded 1.36 and its Current Ratio is at 1.92. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.02.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 29 ’24 when Israeli Erez bought 65,500 shares for $82.29 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RDY now has a Market Capitalization of 11779270656 and an Enterprise Value of 1334221056. As of this moment, Dr.’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.44, and their Forward P/E ratio for the next fiscal year is 17.34. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 25.01. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.28 while its Price-to-Book (P/B) ratio in mrq is 3.24. Its current Enterprise Value per Revenue stands at 0.004 whereas that against EBITDA is 0.016.
Stock Price History:
Over the past 52 weeks, RDY has reached a high of $16.89, while it has fallen to a 52-week low of $12.90. The 50-Day Moving Average of the stock is -7.42%, while the 200-Day Moving Average is calculated to be -6.84%.
Shares Statistics:
For the past three months, RDY has traded an average of 830.55K shares per day and 1208350 over the past ten days. A total of 834.09M shares are outstanding, with a floating share count of 834.06M. Insiders hold about 0.00% of the company’s shares, while institutions hold 14.46% stake in the company. Shares short for RDY as of 1730332800 were 10682565 with a Short Ratio of 12.86, compared to 1727654400 on 10766485. Therefore, it implies a Short% of Shares Outstanding of 10682565 and a Short% of Float of 1.7500000000000002.
Dividends & Splits
According to the company, the forward annual dividend rate for RDY is 0.48, from 8.0 in the trailing year. Against a Trailing Annual Dividend Yield of 0.55865926The stock’s 5-year Average Dividend Yield is 0.72.
